肝细胞癌增长动力学和跨动脉栓塞后的结果:单中心分析
Ken Zhao1, Harrison Blume1, Elena N Petre1
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cancers
|October 29, 2025
概括
快速增长的肝细胞癌 (HCC),以短时间的瘤体积翻倍时间 (TVDT) 表示,与经过动脉栓塞 (TAE) 后的生存率较差有关. 遗传突变与更快的HCC生长没有相关性.
科学领域:
- 肝胆瘤学 肝胆瘤学
- 干预性放射学是干预性的放射学.
- 癌症基因组学 癌症基因组学
背景情况:
- 肝细胞癌 (HCC) 是一种具有重大全球影响的原发性肝癌.
- 跨动脉栓塞 (TAE) 是对不可切除的HCC的常见治疗方法.
- 了解影响治疗反应和生存的因素对于HCC管理至关重要.
研究的目的:
- 调查瘤体积翻倍时间 (TVDT) 与TAE治疗的HCC患者的临床结果之间的关联.
- 评估瘤基因型对HCC的TVDT的影响.
- 为了确定 HCC 的 TAE 后生存的预后因素.
主要方法:
- 对接受TAE的先前未接受治疗的HCC患者进行了回顾性队列研究.
- 从基线横截面成像中使用施瓦茨方程计算的TVDT.
- 为基因突变分析进行的下一代测序.
- 用于生存评估的卡普兰-梅尔和考克斯回归分析.
主要成果:
- 较短的TVDT (≤2.5个月) 与TAE后的整体存活率 (OS) 更差有关 (p=0.011).
- 更糟糕的生存状况的预测因素包括TVDT ≤2.5个月,ECOG性能得分为1-2,AFP>200 ng/mL.
- 多重HCC瘤 (≥5) 预测局部瘤无进展存活率 (LTPFS) 较差 (p=0.002).
- 没有发现任何特定的基因突变与较短的TVDT有关.
结论:
- 较短的TVDT表明瘤快速生长,可能预测TAE治疗的HCC患者的生存状况较差.
- 瘤基因型似乎不是HCC生长速度 (TVDT) 的重要因素.
- TVDT是接受TAE的HCC患者的潜在预后标志物.
相关概念视频
Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


